SE0102309L - Farmaceutisk engång-om-dagen-komposition innehållande brivudin - Google Patents

Farmaceutisk engång-om-dagen-komposition innehållande brivudin

Info

Publication number
SE0102309L
SE0102309L SE0102309A SE0102309A SE0102309L SE 0102309 L SE0102309 L SE 0102309L SE 0102309 A SE0102309 A SE 0102309A SE 0102309 A SE0102309 A SE 0102309A SE 0102309 L SE0102309 L SE 0102309L
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
brivudine
composition containing
time pharmaceutical
containing brivudine
Prior art date
Application number
SE0102309A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE0102309D0 (sv
Inventor
Alessandro Casini
Bettina Stubinski
Attilio Crea
Original Assignee
Berlin Chemie Ag
Menarini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin Chemie Ag, Menarini Ricerche Spa filed Critical Berlin Chemie Ag
Publication of SE0102309D0 publication Critical patent/SE0102309D0/xx
Publication of SE0102309L publication Critical patent/SE0102309L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE0102309A 2001-01-03 2001-06-28 Farmaceutisk engång-om-dagen-komposition innehållande brivudin SE0102309L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI000009A ITMI20010009A1 (it) 2001-01-03 2001-01-03 Composizioni farmaceutica contenente brivudina per la singola somministrazione giornaliera

Publications (2)

Publication Number Publication Date
SE0102309D0 SE0102309D0 (sv) 2001-06-28
SE0102309L true SE0102309L (sv) 2002-07-04

Family

ID=11446384

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102309A SE0102309L (sv) 2001-01-03 2001-06-28 Farmaceutisk engång-om-dagen-komposition innehållande brivudin

Country Status (20)

Country Link
AT (1) AT6141U1 (da)
BE (1) BE1014522A5 (da)
CH (1) CH695662A5 (da)
CZ (1) CZ20012464A3 (da)
DK (1) DK177084B1 (da)
ES (1) ES2192456B1 (da)
FI (1) FI20011446A (da)
FR (1) FR2818907B1 (da)
GB (1) GB2370771A (da)
GR (1) GR1004012B (da)
HR (1) HRPK20010345B3 (da)
HU (1) HUP0102816A3 (da)
IE (1) IE20010413A1 (da)
IT (1) ITMI20010009A1 (da)
NL (1) NL1018431C2 (da)
PL (1) PL348480A1 (da)
PT (1) PT102642B (da)
SE (1) SE0102309L (da)
SK (1) SK287043B6 (da)
UA (1) UA76402C2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2239527B1 (es) * 2004-03-01 2006-11-16 M. Cruz Fernandez Gonzalez Composicion farmacologica de uso topico para el tratamiento del herpes zoster.
CN113712928A (zh) * 2021-09-29 2021-11-30 重庆市力扬医药开发有限公司 经口腔粘膜吸收的溴夫定药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0104857A1 (en) * 1982-09-28 1984-04-04 Beecham Group Plc Deoxyuridine compounds, methods for preparing them and their use in medicine
IT1170232B (it) * 1983-10-31 1987-06-03 Anna Gioia Stendardi Composizioni terapeutiche ad attivita' antivirale
US5446031A (en) * 1991-04-24 1995-08-29 Yamasa Shuyu Kabushiki Kaisha 1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives
DE69726255T2 (de) * 1996-01-19 2004-08-26 Glaxo Group Ltd., Greenford Verwendung von valaciclovir zur herstellung eines arzneimittels zur behandlung von genitalherpes durch einmal tägliche verabreichung

Also Published As

Publication number Publication date
HRP20010345A2 (en) 2003-08-31
NL1018431C2 (nl) 2002-07-05
PL348480A1 (en) 2002-07-15
CH695662A5 (de) 2006-07-31
FI20011446A (fi) 2002-07-04
SE0102309D0 (sv) 2001-06-28
PT102642B (pt) 2003-06-30
BE1014522A5 (fr) 2003-12-02
FI20011446A0 (fi) 2001-07-03
FR2818907B1 (fr) 2006-05-26
GR1004012B (el) 2002-11-01
PT102642A (pt) 2002-07-31
SK9572001A3 (en) 2003-03-04
SK287043B6 (sk) 2009-10-07
GB0110682D0 (en) 2001-06-20
GB2370771A (en) 2002-07-10
UA76402C2 (en) 2006-08-15
CZ20012464A3 (cs) 2002-08-14
FR2818907A1 (fr) 2002-07-05
ITMI20010009A0 (it) 2001-01-03
ES2192456B1 (es) 2005-02-01
HUP0102816A3 (en) 2005-01-28
GR20010100322A (el) 2002-10-08
HRPK20010345B3 (en) 2005-02-28
DK200101019A (da) 2002-07-04
ES2192456A1 (es) 2003-10-01
DK177084B1 (da) 2011-07-11
IE20010413A1 (en) 2003-04-16
HUP0102816A2 (en) 2002-10-28
ITMI20010009A1 (it) 2002-07-03
HU0102816D0 (en) 2001-09-28
AT6141U1 (de) 2003-05-26

Similar Documents

Publication Publication Date Title
EE200000532A (et) Pürimidiini derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud HIV nakkuse raviks, ühend, seda sisaldav farmatseutiline kompositsioon, meetod ühendi ja kompositsiooni valmistamiseks ningkombineeritud preparaat kasutamiseks HIV nakkusera
EA200200812A1 (ru) Фармацевтическая композиция, содержащая низкую дозу энтекавира, и ее применение
BRPI0415007A (pt) método para tratar, prevenir, modificar ou administrar dor, e, composição farmacêutica
HUP0300421A2 (hu) Kezelési eljárás ligand-immunogén konjugátumok felhasználásával
BR0012082A (pt) Formulação farmacêutica para administração compreendendo morfina e seu uso
AU9018898A (en) Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
BR0210489A (pt) Formulação farmacêutica oral, processo para preparar a mesma, uso da mesa, e método para preparar um distúrbio cardiovascular em um paciente
AP2003002763A0 (en) Controlled release formulations for oral administration
PL363313A1 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
DE60128263D1 (de) Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
BR0211198A (pt) Composições farmacêuticas e seu uso
WO2002011694A3 (en) COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
SE0102309L (sv) Farmaceutisk engång-om-dagen-komposition innehållande brivudin
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
EE200200551A (et) Oligosahhariide sisaldav farmatseutiline kompositsioon, oligosahhariidid, nende valmistamine ja raviotstarbeline kasutamine
EA200701091A1 (ru) Противозачаточный фармацевтический препарат
HUP9901935A2 (hu) Gyógyszerek és terápiás szerek és más glikozaminoglikánok (GAG) dózisainak célbajuttatására alkalmas dóziskészlet
NO302360B1 (no) NG-monometyl-L-argininhydrokloridderivater
BR0202759A (pt) Composição farmacêutica de liberação modificada contendo bupropiona como substância ativa
DK1161254T3 (da) Behandling af autoimmune sygdomme med en ekstrakt af amerikansk ginseng
TR200101352A2 (tr) Brivüdin içeren, günde tek dozluk farmasötik bileşim
HUP0301337A2 (hu) Terbinafint tartalmazó orális gyógyszerkészítmények és alkalmazásuk
PT1150981E (pt) Composto nucleosidico terapeutico
MY145885A (en) Controlled release formulations for oral administration

Legal Events

Date Code Title Description
NAV Patent application has lapsed